PEQUI OIL BIGEL WITH ELLAGIC ACID: A NARRATIVE REVIEW ON THE POTENTIAL FOR TREATMENT OF ORAL ULCERS
Authors:
- Pedro Guimarães Sampaio Trajano Dos SantosPSPedro Guimarães Sampaio Trajano Dos Santos
- Maria Do Socorro Orestes CardosoMCMaria Do Socorro Orestes Cardoso
- Carlos Fernando Rodrigues GuaranáCGCarlos Fernando Rodrigues Guaraná
- Eliana Santos Lyra Da PazEPEliana Santos Lyra Da Paz
- Pedro Henrique de Barros FalcãoPFPedro Henrique de Barros Falcão
- Vânia Cavalcanti Ribeiro da SilvaVSVânia Cavalcanti Ribeiro da Silva
- Josué AlvesJAJosué Alves
- Alexandre Batista Lopes Do NascimentoANAlexandre Batista Lopes Do Nascimento
- Vanessa Lessa Cavalcanti De AraújoVAVanessa Lessa Cavalcanti De Araújo
- Priscila ProsiniPPPriscila Prosini
- Rosana Maria Coelho TravassosRTRosana Maria Coelho Travassos
- Vanda Sanderana Macêdo CarneiroVCVanda Sanderana Macêdo Carneiro
Open Access
- 1 October 2025
- journal article
- review article
- Published by Seven Events in ARACÊ
- Vol. 7 (10) , e8594
Abstract
Objective: This narrative review aims to analyze the therapeutic potential of pequi (Caryocar brasiliense) oil–based bigel enriched with ellagic acid for the treatment of oral ulcers, highlighting its anti-inflammatory, antioxidant, and wound-healing properties. Methodology: A non-systematic literature review was conducted using databases such as PubMed, Scopus, and Google Scholar, focusing on studies related to pequi oil, ellagic acid, phytotherapeutic gels, and their applications in oral wound healing. Experimental studies, both in vitro and in vivo, as well as previous reports on the physicochemical characterization and biological activities of bigel formulations, were considered. Results: The evidence reviewed suggests that pequi oil exhibits relevant pharmacological activities, including anti-inflammatory and antimicrobial effects, while ellagic acid contributes with potent antioxidant and healing properties. The combination of these bioactive agents in a bigel system enhances bioavailability, mucoadhesion, and controlled drug release. In preclinical studies, bigels containing ellagic acid accelerated the healing process of induced oral ulcers in animal models, promoting faster re-epithelialization, reduced inflammatory infiltrate, and improved tissue regeneration when compared to control groups. The formulation also showed antimicrobial activity, biocompatibility, and favorable physicochemical stability, supporting its translational potential for clinical use. Conclusion: The pequi oil–ellagic acid bigel demonstrates promising therapeutic effects in the management of oral ulcers, with potential applicability in conditions such as recurrent aphthous stomatitis and oral mucositis. Despite encouraging results, further randomized clinical trials are essential to validate safety, efficacy, and cost-effectiveness in human populations.Keywords
This publication has 3 references indexed in Scilit:
- The effect of ellagic acid on the repair process of periodontal defects related to experimental periodontitis in ratsJournal of Applied Oral Science, 2021
- Cytotoxic effects induced by patulin, deoxynivalenol and toxin T2 individually and in combination in hepatic cells (HepG2)Food and Chemical Toxicology, 2018
- AVALIAÇÃO DA ATIVIDADE CICATRIZANTE DO ÓLEO DE PEQUI (CARYOCAR CORIACEUM WITTM) EM FERIDAS CUTÂNEAS PRODUZIDAS EXPERIMENTALMENTE EM RATOSArquivos do Instituto Biológico, 2010